ALLRAllarity Therapeutics, Inc.

Nasdaq allarity.com


$ 1.05 $ -0.11 (-9.48 %)    

Monday, 06-May-2024 09:43:41 EDT
QQQ $ 437.74 $ 0.79 (0.18 %)
DIA $ 388.38 $ -0.22 (-0.06 %)
SPY $ 514.26 $ 0.49 (0.1 %)
TLT $ 89.82 $ -0.06 (-0.07 %)
GLD $ 215.52 $ 0.46 (0.21 %)
$ 1
$ 1.16
$ 1.07 x 100
$ 1.08 x 300
$ 1.03 - $ 1.40
$ 0.95 - $ 372.00
7,555,562
na
308,945
$ 1.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-08-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-13-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 10-07-2022 06-30-2022 10-Q
8 05-27-2022 03-31-2022 10-Q
9 05-16-2022 09-30-2021 10-Q
10 05-16-2022 12-31-2021 10-K
11 11-23-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-is-nano-cap-allarity-therapeutics-stock-trading-up-on-thursday

Allarity Therapeutics halts Phase 2 trial, citing compelling early results and plans for regulatory advancement. CEO Thomas Jen...

Core News & Articles
Market-Moving News May 2nd
05/02/2024 12:39:37

ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical...

 why-medical-properties-trust-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket

Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced th...

 why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

 allarity-therapeutics-inc-files-prospectus-supplement-to-increase-offering-price-of-common-stock-that-may-be-offered-from-235m-to-32m

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION